UpToDate competitors

UpToDate's competitors include Advanced Oncotherapy, Affymetrix, Fusion Antibodies and Mirna Therapeutics
Add company...
UpToDate
UpToDate's mission is to help clinicians provide the best possible care for their patients.
Advanced Oncotherapy
Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.
Affymetrix
Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell,
Fusion Antibodies
Fusion Antibodies is a CRO that offers a range of world class services in antibody production, development, characterization and optimization.
Mirna Therapeutics
Mirna Therapeutics researches on and develops miRNA-directed human oncology therapies.
Founding Date
Founding Date
1992
Founding Date
1994
Founding Date
1994
Founding Date
2001
Founding Date
2007
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Type
Private
Type
Public
Tags
Locations
Locations
Waltham, US HQ
Zoetermeer, NL
Locations
London, GB HQ
Rolle, CH
Syracuse, US
Locations
Santa Clara, US HQ
Vienna, AT
Shanghai, CN
Singapore, SG
High Wycombe, GB
San Diego, US
see more
Locations
Dunmurry, GB HQ
Locations
Austin, US HQ
Employees
Employees
N/A
Employees
51
Employees
N/A
Employees
2713% increase
Employees
369% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
28.9 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
223.3 m
Facebook likes
Facebook likes
289.8 k
Facebook likes
928
Facebook likes
65 k
Facebook likes
225
Facebook likes
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
804
Twitter followers
9.8 k
Twitter followers
780
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$359.8m (FY, 2015)
Revenue (est.)
£1.9m (FY, 2017)
Revenue (est.)
$2.4m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$110.8m (FY, 2015)
Cost of goods
£952.5k (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$249m (FY, 2015)
Gross profit
£961.5k (FY, 2017)
Gross profit
N/A
Net income
Net income
N/A
Net income
(£10.4m) (FY, 2016)
Net income
$10.1m (FY, 2015)
Net income
£120k (FY, 2017)
Net income
($40.4m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 2.5m
Total funding raised
$ 77.8m
For sources of this data, please see the company profileDownload Excel

View company profiles

Advanced Oncotherapy
HQ
London, GB
Employees
51

Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.

View company
Affymetrix
HQ
Santa Clara, US

Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell,

View company
Fusion Antibodies
HQ
Dunmurry, GB
Employees
27↑ 13% increase

Fusion Antibodies is a CRO that offers a range of world class services in antibody production, development, characterization and optimization.

View company
Mirna Therapeutics
HQ
Austin, US
Employees
36↑ 9% increase

Mirna Therapeutics researches on and develops miRNA-directed human oncology therapies.

View company